Exclusive: FDA grants RMAT designation to Enlivex’s Allocetra for knee OA

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 9/20/2026

1. SPY
2. XENE
3. NUE
4. HUBS
5. RTB
6. ONON
7. AAPL
8. TRMD
9. ACN
10. AZN

Go back to Exclusive: FDA grants RMAT designation to Enlivex’s Allocetra for knee OA
Enliven Marketing Technologies Corporation (NASDAQ: ENLV) Delayed: 0.81 +0.08 (10.96%)
Previous Close $0.73    52 Week High $0.94 
Open $0.73    52 Week Low $0.47 
Day High $0.82    P/E N/A 
Day Low $0.71    EPS $-0.11 
Volume 350,080